Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marylyn M Addo

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
Ebiomedicine|April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationChristine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
Journal of Virology|March 30, 2005
The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine designMarcus Altfeld, Todd M Allen, Elizabeth T Kalife, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinShawn M Sumida, Diana M Truitt, Angelique A C Lemckert, et al.
Frontiers in Immunology|February 26, 2026
Long non-coding RNAs in response to Ebola virus vaccine-induced immunityIzabela Mamede, Thomaz Luschër-Dias, Isabelle Franco Moscardini, et al.
Journal of Clinical Medicine|June 2, 2021
Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020Thomas Theo Brehm, Andreas Heyer, Kevin Roedl, et al.
Frontiers in Immunology|March 19, 2026
Correction: Long non-coding RNAs in response to Ebola virus vaccine-induced immunityIzabela Mamede, Thomaz Luschër-Dias, Isabelle Franco Moscardini, et al.
Ebiomedicine|December 31, 2023
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccineIvan Odak, Lennart Riemann, Inga Sandrock, et al.
The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trialTill Koch, Christine Dahlke, Anahita Fathi, et al.
The Journal of Experimental Medicine|April 7, 2004
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infectionRika Draenert, Sylvie Le Gall, Katja J Pfafferott, et al.
AIDS Research and Human Retroviruses|June 10, 2004
Differences in the expressed HLA class I alleles effect the differential clustering of HIV type 1-specific T cell responses in infected Chinese and caucasiansXu G Yu, Marylyn M Addo, Beth A Perkins, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
Ebiomedicine|April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationChristine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
Journal of Virology|March 30, 2005
The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine designMarcus Altfeld, Todd M Allen, Elizabeth T Kalife, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinShawn M Sumida, Diana M Truitt, Angelique A C Lemckert, et al.
Frontiers in Immunology|February 26, 2026
Long non-coding RNAs in response to Ebola virus vaccine-induced immunityIzabela Mamede, Thomaz Luschër-Dias, Isabelle Franco Moscardini, et al.
Journal of Clinical Medicine|June 2, 2021
Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020Thomas Theo Brehm, Andreas Heyer, Kevin Roedl, et al.
Frontiers in Immunology|March 19, 2026
Correction: Long non-coding RNAs in response to Ebola virus vaccine-induced immunityIzabela Mamede, Thomaz Luschër-Dias, Isabelle Franco Moscardini, et al.
Ebiomedicine|December 31, 2023
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccineIvan Odak, Lennart Riemann, Inga Sandrock, et al.
The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trialTill Koch, Christine Dahlke, Anahita Fathi, et al.
The Journal of Experimental Medicine|April 7, 2004
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infectionRika Draenert, Sylvie Le Gall, Katja J Pfafferott, et al.
AIDS Research and Human Retroviruses|June 10, 2004
Differences in the expressed HLA class I alleles effect the differential clustering of HIV type 1-specific T cell responses in infected Chinese and caucasiansXu G Yu, Marylyn M Addo, Beth A Perkins, et al.
Pageof 19